← All trials
NCT04905914
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 21, 2021
- Primary completion
- Feb 28, 2023
- Completion date
- Apr 30, 2023
- First posted
- May 28, 2021
- Last posted
- Sep 9, 2021
- Enrollment
- 45
- Arms / groups
- 5 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Atrin PharmaceuticalsLead sponsor
- Harvard UniversityOverall official - principal investigator
- Atrin PharmaceuticalsStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.